XWAR
MDG
Market cap71mUSD
Jul 09, Last price
27.00PLN
1D
-0.37%
1Q
4.05%
Jan 2017
-91.23%
IPO
28.57%
Name
Medicalgorithmics SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2005 and headquartered in Warsaw, Poland, Medicalgorithmics S.A. is a prominent provider of cardiac diagnostic solutions, serving markets in Poland, the United States, and globally. The company offers an array of advanced products, including PocketECG, a comprehensive diagnostic system for arrhythmia detection that furnishes detailed ECG signals, data analysis, and exhaustive reports. Another key offering is PocketECG CRS, specifically designed for monitoring patients during cardiac rehabilitation. Its technological portfolio also encompasses ECG TechBot, a software program that utilizes algorithms for the automated analysis and interpretation of ECG signals, and PatchECG, a device enabling single-channel, offline heart monitoring. Additionally, PocketECG IV enhances the core PocketECG device by enabling continuous ECG signal transmission via LTE connectivity. Beyond its innovative devices, Medicalgorithmics S.A. delivers services in information technology, biotechnology, ECG monitoring, and scientific research and development, alongside manufacturing and distributing electro-medical equipment.
IPO date
Nov 09, 2011
Employees
122
Domiciled in
PL
Incorporated in
PL
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||